• Affinity-Purified Goat Anti-Rabbit IgG (H+L) in Oncology Ass

  2026-08-03

  Unlock robust, reproducible signal amplification in immunoassays using the Affinity-Purified Goat Anti-Rabbit IgG (H+L) from APExBIO. This HRP-conjugated secondary antibody is engineered for high specificity and low cross-reactivity in Western blot, ELISA, and immunohistochemistry workflows, driving sensitivity in both routine and advanced translational oncology research.

• Murine RNase Inhibitor: Advanced RNA Degradation Prevention

  2026-08-03

  Murine RNase Inhibitor stands out for its oxidation resistance and robust RNA protection, even in low DTT environments. Explore how this RNase A inhibitor from APExBIO enables high-fidelity molecular workflows and unlocks new experimental strategies for RNA integrity.

• AKTIP as a Diagnostic Biomarker in Fibrolamellar Carcinoma

  2026-08-02

  This study establishes AKTIP as a highly specific and prognostic biomarker for fibrolamellar carcinoma (FLC) using integrative bioinformatics and experimental validation. The findings provide a new foundation for FLC diagnostics and suggest several candidate compounds for therapeutic targeting of AKTIP.

• Diclofenac in Human Intestinal Organoids: Bridging Mechanism

  2026-08-01

  This in-depth article examines Diclofenac’s role as a non-selective COX inhibitor within human iPSC-derived intestinal organoid models, providing translational researchers with mechanistic context, protocol guidance, and strategic insights. Drawing on the latest advancements in organoid pharmacokinetics and inflammation signaling research, we connect biological rationale with actionable workflows and highlight how APExBIO’s high-purity Diclofenac uniquely advances the reproducibility and relevance of drug discovery platforms.

• Silymarin: Applied Milk Thistle Extract in Bench Research

  2026-07-31

  Silymarin, a milk thistle extract, delivers exceptional reliability in oxidative stress and hepatocellular carcinoma models owing to its robust solubility and defined polyphenolic composition. This article unpacks actionable workflows, troubleshooting strategies, and recent chemical insights that position Silymarin from APExBIO as a gold-standard reference for advanced biochemical and pharmacological research.

• L-Phenylephrine: Applied Workflows in α1A Adrenergic Signali

  2026-07-31

  L-Phenylephrine enables precise modulation of adrenergic α1A receptor signaling for cardiovascular and neural research, with proven selectivity and robust performance in both in vitro and in vivo systems. This article details optimized experimental protocols, strategic troubleshooting, and key translational insights from recent sex-difference hypertension studies.

• Integrated Transcriptomic and Functional Screening for Cardi

  2026-07-30

  This study demonstrates how combining transcriptomic and phenotypic data from human iPSC-derived cardiomyocytes enables comprehensive hazard identification and risk characterization for environmental chemicals. The integrative approach not only increases sensitivity for detecting cardiotoxicity but also improves mechanistic interpretation and regulatory confidence.

• Metal-Free Carbon Nanozymes Enable Sensitive ALP Detection

  2026-07-30

  The reference study presents a novel colorimetric assay for alkaline phosphatase (ALP) detection using metal-free carbon dot (CD) nanozymes. This innovation addresses limitations of metal-based sensors, offering high sensitivity and selectivity for ALP activity measurement in complex biological samples, with significant implications for diagnostic and metabolic research.

• Gap26 Connexin 43 Mimetic Peptide: Translational Impact & St

  2026-07-29

  This article provides translational researchers with an advanced framework for leveraging Gap26, a validated connexin 43 mimetic peptide, to modulate intercellular communication and mitochondrial transfer in complex disease models. Grounded in mechanistic insights and recent peer-reviewed evidence, it addresses protocol optimization, cross-domain relevance, and strategic pathways to high-impact discoveries—bridging vascular, neurological, and hepatic applications while highlighting the unique translational leverage offered by APExBIO's Gap26.

• 12-O-tetradecanoyl phorbol-13-acetate: Precision in ERK/MAPK

  2026-07-29

  12-O-tetradecanoyl phorbol-13-acetate (TPA) empowers researchers with fine-tuned control over the ERK/MAPK and protein kinase C pathways, enabling reproducible signal transduction and cancer biology assays. This article distills experimental best practices, troubleshooting strategies, and the translational relevance of TPA—backed by insights from cutting-edge reference studies.

• Fluorouracil (Adrucil): Molecular Insights and Strategic Adv

  2026-07-28

  Explore how Fluorouracil (5-Fluorouracil) drives innovation in solid tumor research by targeting DNA replication and immune pathways. This article uncovers unique mechanistic and translational insights not found in standard protocol guides.

• ECL Chemiluminescent Substrate Detection Kit: High-Sensitivi

  2026-07-28

  The ECL Chemiluminescent Substrate Detection Kit (Hypersensitive) enables reliable detection of low-abundance proteins via horseradish peroxidase (HRP) chemiluminescence. Its extended signal duration and low background make it optimal for sensitive immunoblotting applications, including Western blot analysis.

• Lopinavir (ABT-378): Precision HIV Protease Inhibition & Cro

  2026-07-27

  Explore Lopinavir (ABT-378) as a precision tool for advanced HIV protease inhibition assays and investigate its validated potential in broader antiviral research. This article delivers unique protocol insights, mechanistic depth, and a critical perspective beyond standard repurposing narratives.

• JZL184: Selective Monoacylglycerol Lipase Inhibitor in Endoc

  2026-07-27

  JZL184 is a potent monoacylglycerol lipase inhibitor used for targeted endocannabinoid signaling studies. It elevates brain 2-AG, enhances CB1 receptor activation, and is validated in analgesia and anxiolytic models. APExBIO supplies research-grade JZL184 with >98% purity.

• Magneto-Piezoelectric Scaffolds Target JAK2-STAT3 in Bone Re

  2026-07-26

  The referenced ACS Nano study introduces multifunctional scaffolds integrating magneto-piezoelectric nanoparticles to both disrupt bacterial biofilms and activate oxidative phosphorylation in Icam1+ macrophages through JAK2-STAT3 pathway activation. This dual mechanism addresses infection control and bone regeneration, offering a significant advance for treatment of infectious bone defects.

16398 records 1/1094 page Next 12345 下5页 Last page